Amyloid β-Peptide (10-20) (human)
Discontinued ProductAmyloid β-Peptide (10-20) (human) (Cat. No. 1892) has been withdrawn from sale for commercial reasons.
Soluble amyloid β-peptide fragment that is a substrate for gelatinase A/type IV collagenase/MMP-2 and APP secretase; cleaved between Lys16 and Leu17.
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Miyazaki et al (1993) A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362 839 PMID: 8479521
Roher et al (1994) Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A. Biochem.Biophys.Res.Commun. 205 1755 PMID: 7811262
View Related Products by Target
Keywords: Amyloid b-peptide (10-20) (human), Amyloid b-peptide (10-20) (human) supplier, β-Amyloid, beta-Amyloid, b-amyloid, β-peptide, beta-peptide, fragment, substrates, gelatinase, A, type, IV, collagenase, MMP-2, metalloproteinase, metalloprotease, amyloid, precursor, protein, APP, secretase, Amyloid, beta, peptide, (10-20), (human), amyloidbeta, b-AP, Beta, Peptides, Enzyme, Substrates, /, Activators, Matrix, Metalloprotease, Other, Proteases, 1892, Tocris Bioscience
Citations for Amyloid β-Peptide (10-20) (human)
Citations are publications that use Tocris products.
Currently there are no citations for Amyloid β-Peptide (10-20) (human).
Reviews for Amyloid β-Peptide (10-20) (human)
There are currently no reviews for this product. Be the first to review Amyloid β-Peptide (10-20) (human) and earn rewards!
Have you used Amyloid β-Peptide (10-20) (human)?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.